Diffusion tensor imaging in amyotrophic lateral sclerosis: machine learning for biomarker development

A Behler, HP Müller, AC Ludolph… - International journal of …, 2023 - mdpi.com
Diffusion tensor imaging (DTI) allows the in vivo imaging of pathological white matter
alterations, either with unbiased voxel-wise or hypothesis-guided tract-based analysis …

Biomarkers in amyotrophic lateral sclerosis: current status and future prospects

R McMackin, P Bede, C Ingre, A Malaspina… - Nature Reviews …, 2023 - nature.com
Disease heterogeneity in amyotrophic lateral sclerosis poses a substantial challenge in drug
development. Categorization based on clinical features alone can help us predict the …

Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers

P Bede, D Lulé, HP Müller, EL Tan, J Dorst… - Journal of …, 2023 - Springer
Background The characterisation of presymptomatic disease-burden patterns in
asymptomatic mutation carriers has a dual academic and clinical relevance. The …

Overview of nomenclature and diagnosis of amyotrophic lateral sclerosis

R Xu - Annals of Medicine, 2024 - Taylor & Francis
The nomenclature of amyotrophic lateral sclerosis (ALS) currently is blurred, indistinct and
no accurate and haven't been properly updated since the first description, which is far from …

Limbic network and papez circuit involvement in ALS: imaging and clinical profiles in GGGGCC hexanucleotide carriers in C9orf72 and C9orf72-negative patients

F Christidi, J Kleinerova, EL Tan, S Delaney… - …, 2024 - pmc.ncbi.nlm.nih.gov
Simple Summary Amyotrophic lateral sclerosis (ALS) is the most common form of Motor
Neuron Disease and is traditionally associated with motor cortex, brainstem and spinal cord …

Sequential alterations in diffusion metrics as correlates of disease severity in amyotrophic lateral sclerosis

HP Müller, A Behler, M Münch, J Dorst, AC Ludolph… - Journal of …, 2023 - Springer
Background and objective The neuropathology of amyotrophic lateral sclerosis (ALS)
follows a regional distribution pattern in the brain with four stages. Using diffusion tensor …

Toward diffusion tensor imaging as a biomarker in neurodegenerative diseases: technical considerations to optimize recordings and data processing

HP Müller, J Kassubek - Frontiers in Human Neuroscience, 2024 - frontiersin.org
Neuroimaging biomarkers have shown high potential to map the disease processes in the
application to neurodegenerative diseases (NDD), eg, diffusion tensor imaging (DTI). For …

A Bayesian Imprecise Classification method that weights instances using the error costs

S Moral-García, T Coolen-Maturi, FPA Coolen… - Applied Soft …, 2024 - Elsevier
In practical applications, Bayesian classification methods have been successfully employed.
The Naïve Bayes algorithm (NB) is a quick, successful, and well-known Bayesian …

The gap between academic advances and therapy development in motor neuron disease

P Bede, PF Pradat - Current Opinion in Neurology, 2023 - journals.lww.com
Despite the universal recognition of the fundamental clinical, genetic and pathological
heterogeneity of amyotrophic lateral sclerosis (ALS), the expectation that the same drug may …

[HTML][HTML] Clinical, Cortical, Subcortical, and White Matter Features of Right Temporal Variant FTD

J Kleinerova, MC McKenna, M Finnegan, A Tacheva… - Brain Sciences, 2024 - mdpi.com
The distinct clinical and radiological characteristics of right temporal variant FTD have only
been recently recognized. Methods: Eight patients with right temporal variant FTD were …